GB00BDCPN049 - Common Stock

Overall **CCEP** gets a fundamental rating of **5** out of 10. We evaluated **CCEP** against 34 industry peers in the **Beverages** industry. There are concerns on the financial health of **CCEP** while its profitability can be described as average. **CCEP** has a correct valuation and a medium growth rate.

In the past 5 years **CCEP** has always been profitable.

Each year in the past 5 years **CCEP** had a positive operating cash flow.

The **Return On Assets** of **CCEP** (**5.69%**) is comparable to the rest of the industry.

Looking at the **Return On Invested Capital**, with a value of **7.86%**, **CCEP** is in line with its industry, outperforming **55.88%** of the companies in the same industry.

Measured over the past 3 years, the **Average Return On Invested Capital** for **CCEP** is significantly below the industry average of **11.59%**.

The last **Return On Invested Capital** (**7.86%**) for **CCEP** is above the 3 year average (**5.61%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.69% | ||

ROE | 21.84% | ||

ROIC | 7.86% |

ROA(3y)3.7%

ROA(5y)4.39%

ROE(3y)14.16%

ROE(5y)14.81%

ROIC(3y)5.61%

ROIC(5y)6.33%

With a decent **Profit Margin** value of **9.41%**, **CCEP** is doing good in the industry, outperforming **67.65%** of the companies in the same industry.

Looking at the **Gross Margin**, with a value of **36.29%**, **CCEP** is doing worse than **70.59%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 12.62% | ||

PM | 9.41% | ||

GM | 36.29% |

OM growth 3Y-1.19%

OM growth 5Y1.59%

PM growth 3Y-1.36%

PM growth 5Y6.96%

GM growth 3Y-1.9%

GM growth 5Y-1.44%

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), **CCEP** is creating some value.

Compared to 5 years ago, **CCEP** has less shares outstanding

An Altman-Z score of **1.90** indicates that **CCEP** is not a great score, but indicates only limited risk for bankruptcy at the moment.

With a **Altman-Z score** value of **1.90**, **CCEP** perfoms like the industry average, outperforming **47.06%** of the companies in the same industry.

A Debt/Equity ratio of **1.27** is on the high side and indicates that **CCEP** has dependencies on debt financing.

Looking at the **Debt to Equity ratio**, with a value of **1.27**, **CCEP** is doing worse than **79.41%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.27 | ||

Debt/FCF | 6.26 | ||

Altman-Z | 1.9 |

ROIC/WACC9.29

WACC6.53%

A Current Ratio of **0.85** indicates that **CCEP** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.85 | ||

Quick Ratio | 0.66 |

The **Earnings Per Share** has grown by an impressive **20.54%** over the past year.

The **Earnings Per Share** has been growing by **18.64%** on average over the past years. This is quite good.

The **Revenue** has grown by **11.73%** in the past year. This is quite good.

Measured over the past years, **CCEP** shows a quite strong growth in **Revenue**. The Revenue has been growing by **9.38%** on average per year.

EPS 1Y20.54%

EPS 3Y12.35%

EPS 5Y18.64%

EPS growth Q2Q27.44%

Revenue growth 1Y11.73%

Revenue growth 3Y12.96%

Revenue growth 5Y9.38%

Revenue growth Q2Q8.42%

The **Earnings Per Share** is expected to grow by **8.94%** on average over the next years. This is quite good.

EPS Next Y8.89%

EPS Next 2Y9.01%

EPS Next 3Y8.94%

EPS Next 5YN/A

Revenue Next Year6.9%

Revenue Next 2Y6.49%

Revenue Next 3Y5.69%

Revenue Next 5Y3.91%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

The **Price/Earnings** ratio is **16.10**, which indicates a correct valuation of **CCEP**.

Based on the **Price/Earnings** ratio, **CCEP** is valued cheaper than 85.29% of the companies in the same industry.

Based on the **Price/Forward Earnings** ratio of **14.54**, the valuation of **CCEP** can be described as correct.

82.35% of the companies in the same industry are more expensive than **CCEP**, based on the **Price/Forward Earnings** ratio.

The average S&P500 **Price/Forward Earnings** ratio is at **18.89**. **CCEP** is valued slightly cheaper when compared to this.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 16.1 | ||

Fwd PE | 14.54 |

Based on the **Enterprise Value to EBITDA** ratio, **CCEP** is valued a bit cheaper than the industry average as 79.41% of the companies are valued more expensively.

Compared to the rest of the industry, the **Price/Free Cash Flow** ratio of **CCEP** indicates a rather cheap valuation: **CCEP** is cheaper than 85.29% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 14.55 | ||

EV/EBITDA | 11.6 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

The decent profitability rating of **CCEP** may justify a higher PE ratio.

PEG (NY)1.81

PEG (5Y)0.86

EPS Next 2Y9.01%

EPS Next 3Y8.94%

With a **Yearly Dividend Yield** of **2.93%**, **CCEP** has a reasonable but not impressive dividend return.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.93% |

On average, the dividend of **CCEP** grows each year by **10.59%**, which is quite nice.

Dividend Growth(5Y)10.59%

Div Incr Years2

Div Non Decr Years2

DP48.08%

EPS Next 2Y9.01%

EPS Next 3Y8.94%

**COCA-COLA EUROPACIFIC PARTNE**

NASDAQ:CCEP (9/28/2023, 7:00:00 PM)

After market: 62.8 0 (0%)**62.8**

**+0.49 (+0.79%) **

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryBeverages

Earnings (Last)08-03 2023-08-03

Earnings (Next)N/A N/A

Inst Owners28.97%

Inst Owner Change1.9%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap28.82B

Analysts79.17

Price Target72.2 (14.97%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.93% |

Dividend Growth(5Y)10.59%

DP48.08%

Div Incr Years2

Div Non Decr Years2

Ex-Date05-11 2023-05-11 (0.74)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

PT rev (1m)2.1%

PT rev (3m)3.79%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0.43%

EPS NY rev (3m)3.16%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-0.14%

Revenue NY rev (3m)1.9%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 16.1 | ||

Fwd PE | 14.54 | ||

P/S | 1.52 | ||

P/FCF | 14.55 | ||

P/OCF | 10.57 | ||

P/B | 3.52 | ||

P/tB | N/A | ||

EV/EBITDA | 11.6 |

EPS(TTM)3.9

EY6.21%

EPS(NY)4.32

Fwd EY6.88%

FCF(TTM)4.32

FCFY6.87%

OCF(TTM)5.94

OCFY9.46%

SpS41.38

BVpS17.82

TBVpS-20.77

PEG (NY)1.81

PEG (5Y)0.86

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.69% | ||

ROE | 21.84% | ||

ROCE | 10.81% | ||

ROIC | 7.86% | ||

ROICexc | 8.65% | ||

ROICexgc | 60.65% | ||

OM | 12.62% | ||

PM | 9.41% | ||

GM | 36.29% | ||

FCFM | 10.43% |

ROA(3y)3.7%

ROA(5y)4.39%

ROE(3y)14.16%

ROE(5y)14.81%

ROIC(3y)5.61%

ROIC(5y)6.33%

ROICexc(3y)6.41%

ROICexc(5y)6.87%

ROICexgc(3y)49.88%

ROICexgc(5y)42.74%

ROCE(3y)7.55%

ROCE(5y)8.55%

ROICexcg growth 3Y37%

ROICexcg growth 5Y28.74%

ROICexc growth 3Y1.99%

ROICexc growth 5Y5.73%

OM growth 3Y-1.19%

OM growth 5Y1.59%

PM growth 3Y-1.36%

PM growth 5Y6.96%

GM growth 3Y-1.9%

GM growth 5Y-1.44%

F-Score6

Asset Turnover0.6

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.27 | ||

Debt/FCF | 6.26 | ||

Debt/EBITDA | 3.21 | ||

Cap/Depr | 87.61% | ||

Cap/Sales | 3.92% | ||

Profit Quality | 110.86% | ||

Current Ratio | 0.85 | ||

Quick Ratio | 0.66 | ||

Altman-Z | 1.9 |

F-Score6

WACC6.53%

ROIC/WACC9.29

Cap/Depr(3y)62.35%

Cap/Depr(5y)79.69%

Cap/Sales(3y)3.52%

Cap/Sales(5y)4.16%

Profit Quality(3y)180.63%

Profit Quality(5y)158.8%

Growth

EPS 1Y20.54%

EPS 3Y12.35%

EPS 5Y18.64%

EPS growth Q2Q27.44%

EPS Next Y8.89%

EPS Next 2Y9.01%

EPS Next 3Y8.94%

EPS Next 5YN/A

Revenue growth 1Y11.73%

Revenue growth 3Y12.96%

Revenue growth 5Y9.38%

Revenue growth Q2Q8.42%

Revenue Next Year6.9%

Revenue Next 2Y6.49%

Revenue Next 3Y5.69%

Revenue Next 5Y3.91%

EBIT growth 1Y15.03%

EBIT growth 3Y11.61%

EBIT growth 5Y11.12%

EBIT Next Year51.18%

EBIT Next 3Y20.13%

EBIT Next 5Y13.72%

FCF growth 1Y7.13%

FCF growth 3Y21.39%

FCF growth 5Y16.12%

OCF growth 1Y26.45%

OCF growth 3Y15.48%

OCF growth 5Y12.56%